Human PRKCI protein (Recombinant) (N-His) (STJP004706)

SKU:
STJP004706
$443.48 - $1,940.63
Free Shipping
Processing The item has been added

Host: E. coli
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description : Recombinant-Human PRKCI-N-His protein was developed from e. coli and has a target region of N-His. For use in research applications.
Formulation: Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.
Storage Instruction: Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at-20 to-80°C for twelve months from the date of receipt.
Gene Symbol: PRKCI
Gene ID: 5584
Uniprot ID: KPCI_HUMAN
Immunogen Region: Ile375-Val596
Immunogen: Homo sapiens (Human)
Post Translational Modifications Phosphorylation at Thr-412 in the activation loop is not mandatory for activation. Upon neuronal growth factor (NGF) stimulation, phosphorylated by SRC at Tyr-265, Tyr-280 and Tyr-334. Phosphorylation at Tyr-265 facilitates binding to KPNB1/importin-beta regulating entry of PRKCI into the nucleus. Phosphorylation on Tyr-334 is important for NF-kappa-B stimulation. Phosphorylated at Thr-564 during the initial phase of long term potentiation.
Function Calcium- and diacylglycerol-independent serine/ threonine-protein kinase that plays a general protective role against apoptotic stimuli, is involved in NF-kappa-B activation, cell survival, differentiation and polarity, and contributes to the regulation of microtubule dynamics in the early secretory pathway. Is necessary for BCR-ABL oncogene-mediated resistance to apoptotic drug in leukemia cells, protecting leukemia cells against drug-induced apoptosis. In cultured neurons, prevents amyloid beta protein-induced apoptosis by interrupting cell death process at a very early step. In glioblastoma cells, may function downstream of phosphatidylinositol 3-kinase (PI(3)K) and PDPK1 in the promotion of cell survival by phosphorylating and inhibiting the pro-apoptotic factor BAD. Can form a protein complex in non-small cell lung cancer (NSCLC) cells with PARD6A and ECT2 and regulate ECT2 oncogenic activity by phosphorylation, which in turn promotes transformed growth and invasion. In response to nerve growth factor (NGF), acts downstream of SRC to phosphorylate and activate IRAK1, allowing the subsequent activation of NF-kappa-B and neuronal cell survival. Functions in the organization of the apical domain in epithelial cells by phosphorylating EZR. This step is crucial for activation and normal distribution of EZR at the early stages of intestinal epithelial cell differentiation. Forms a protein complex with LLGL1 and PARD6B independently of PARD3 to regulate epithelial cell polarity. Plays a role in microtubule dynamics in the early secretory pathway through interaction with RAB2A and GAPDH and recruitment to vesicular tubular clusters (VTCs). In human coronary artery endothelial cells (HCAEC), is activated by saturated fatty acids and mediates lipid-induced apoptosis. Involved in early synaptic long term potentiation phase in CA1 hippocampal cells and short term memory formation.
Protein Name Protein Kinase C Iota Type
Atypical Protein Kinase C-Lambda/Iota
Prkc-Lambda/Iota
Apkc-Lambda/Iota
Npkc-Iota
Database Links Reactome: R-HSA-1912408
Reactome: R-HSA-209543
Reactome: R-HSA-420029
Reactome: R-HSA-9755511
Cellular Localisation Cytoplasm
Membrane
Endosome
Nucleus
Transported Into The Endosome Through Interaction With Sqstm1/P62
After Phosphorylation By Src
Transported Into The Nucleus Through Interaction With Kpnb1
Colocalizes With Cdk7 In The Cytoplasm And Nucleus
Transported To Vesicular Tubular Clusters (Vtcs) Through Interaction With Rab2a
Alternative Protein Names Protein Kinase C Iota Type protein
Atypical Protein Kinase C-Lambda/Iota protein
Prkc-Lambda/Iota protein
Apkc-Lambda/Iota protein
Npkc-Iota protein
PRKCI protein
DXS1179E protein

Information sourced from Uniprot.org